信达生物(01801):国家药监局受理FGFR1/2/3抑制剂(pemigatinib片)的新适应症上市申请 _ 东方财富网 eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.
信达生物(01801):国家药监局受理达伯舒联合达攸同用于治疗一线肝癌患者的新适应症申请 _ 东方财富网 eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.